FDA says current dose of GSK, Vir COVID therapy likely not effective against BA.2 variant Reuters Mar 28, 2022 The FDA’s move comes as a blow to the companies which have seen high demand for Sotrovimab after it became one of the few COVID-19…
US FDA authorises Eli Lilly’s COVID-19 antibody drug Reuters Feb 14, 2022 The FDA authorised bebtelovimab for emergency use in patients with mild-to-moderate COVID-19 who are at high risk of progression…
